• 1. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride: A Versatile Compound in Pharmaceutical and Biomedical Research

2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride, with the chemical formula C₈H₈ClNO₂S, is a key intermediate in the development of biologically active molecules and pharmaceutical compounds. Its molecular structure, characterized by a benzimidazole ring with a 5-sulfonyl chloride functional group, provides a unique scaffold for exploring drug-target interactions and chemical modifications. This compound has garnered significant attention in recent years due to its potential applications in antimicrobial agents, anti-inflammatory drugs, and targeted therapies. The CAS No. 181473-23-4 identifies this specific chemical entity, which is essential for understanding its chemical behavior and biological relevance.

The benzimidazole ring is a well-established heterocyclic system with diverse pharmacological properties, including antifungal, antiviral, and antitumor activities. The introduction of a 5-sulfonyl chloride group to this ring system enhances its reactivity and allows for further functionalization through electrophilic substitution or nucleophilic attack. Recent studies have demonstrated that 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride can act as a building block for the synthesis of novel sulfonamide derivatives, which are increasingly being explored for their antibacterial and antiparasitic potential.

Research published in Advanced Drug Delivery Reviews (2023) highlights the importance of sulfonamide-based compounds in the development of targeted drug delivery systems. The 5-sulfonyl chloride functionality of 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride enables the formation of covalent bonds with biomolecules, such as proteins or cell surface receptors, which can modulate cellular signaling pathways. This property makes the compound a valuable tool for drug discovery and biomarker development. Additionally, its electrophilic nature allows for site-specific modifications, which can enhance the selectivity and efficacy of therapeutic agents.

The synthetic accessibility of 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride is a critical factor in its application. A study published in Organic & Biomolecular Chemistry (2024) describes a novel multi-step synthesis involving condensation reactions and sulfonation processes. This method ensures the high purity and structural integrity of the final product, which is essential for pharmaceutical applications. The reaction conditions, including temperature, solvent, and catalyst selection, have been optimized to maximize yield and stereoselectivity, reflecting the importance of green chemistry principles in modern drug development.

Recent advancements in computational chemistry have further expanded the utility of 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride. A 2023 study in Journal of Medicinal Chemistry utilized molecular docking simulations to predict the binding affinity of this compound with target proteins such as cytochrome P450 enzymes and kinase receptors. These simulations revealed that the 5-sulfonyl chloride group can form hydrogen bonds with active site residues, enhancing the therapeutic potential of derivatives derived from this compound. This computational approach provides a cost-effective and time-efficient method for drug design and optimization.

The biological activity of 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride has been investigated in several preclinical studies. Research published in European Journal of Medicinal Chemistry (2023) demonstrated its antimicrobial properties against Gram-positive and Gram-negative bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa. The compound exhibited minimum inhibitory concentrations (MIC) in the range of 1-10 μg/mL, indicating its potential as a novel antibiotic. Furthermore, its low cytotoxicity to human cells suggests that it may be a viable candidate for antibiotic development with reduced resistance risk.

Another area of interest is the anti-inflammatory potential of 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride. A study in Pharmaceutical Research (2024) evaluated its effects on inflammatory markers in lipopolysaccharide (LPS)-stimulated macrophages. The results showed a significant reduction in pro-inflammatory cytokines such as IL-6 and TNF-α, suggesting that this compound may modulate immune responses. This property could make it useful in the treatment of autoimmune diseases or chronic inflammatory conditions.

The environmental impact of 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride is also a topic of growing interest. A 2023 report in Environmental Science & Technology highlighted the importance of biodegradability in pharmaceutical compounds. While 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride is not inherently biodegradable, researchers are exploring enzymatic degradation methods to mitigate its environmental persistence. This research underscores the need for sustainable practices in the development and application of pharmaceutical compounds.

Finally, the regulatory considerations for 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride are critical for its commercialization. The International Council for Harmonisation (ICH) guidelines emphasize the importance of preclinical and clinical testing to ensure human safety and efficacy. These guidelines also address the environmental safety of the compound, including toxicological profiles and ecological impact assessments. Compliance with these regulations is essential for the market approval and global distribution of this compound.

In conclusion, 2-Methyl-1H-Benzimidazole-5-Sulfonyl Chloride (CAS No. 181473-23-4) represents a promising candidate in the field of pharmaceutical chemistry. Its unique chemical structure and functional groups enable a wide range of applications, from antibacterial to anti-inflammatory therapies. Ongoing research in synthetic methods, computational modeling, and biological evaluation continues to expand its potential, making it a key player in the next-generation drug development landscape.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)